Integre Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2.13M Sell
7,060
-672
-9% -$185K 1.21% 33
2019
Q3
$1.86M Hold
7,732
1.1% 41
2019
Q2
$2.18M Buy
+7,732
New +$2.11M 1.25% 35

Other funds holding ELV

Integre Asset Management's ELV Position: Q4 2019 in Review

Integre Asset Management reduced its Elevance Health (ELV) stake by 8.7% in Q4 2019, selling an estimated $185K and leaving 7,060 shares worth $2.13M. The position accounts for 1.21% of the portfolio, ranked #33.

Integre Asset Management first reported a position in ELV in Q2 2019 and has held it in 3 quarters since. The position peaked at $2.18M in Q2 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Integre Asset Management held 7,060 shares of Elevance Health worth $2.13M as of Q4 2019.
  • Integre Asset Management sold 672 Elevance Health shares in Q4 2019, an estimated $185K.
  • Elevance Health made up 1.21% of Integre Asset Management's portfolio in Q4 2019, its #33 holding.
  • Integre Asset Management first reported a position in Elevance Health in Q2 2019 and has held it in 3 quarters since.
  • Integre Asset Management's Elevance Health position peaked at $2.18M in Q2 2019.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Integre Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.